SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-08-25 20:20
Tx date 2020-08-20
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Holder: Kanya Adam (Indirect Ownership)
Common Shares
97 - Other

-16,460 vol
0
Filed 2020-08-24 18:47
Tx date 2020-08-20
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-45,000 vol
210,186
Filed 2020-08-17 19:39
Tx date 2020-08-17
$XENE
Xenon Pharmaceuticals Inc.
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
100,000
Filed 2020-08-17 19:35
Tx date 2020-08-17
$XENE
Xenon Pharmaceuticals Inc.
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-06-10 18:58
Tx date 2020-06-09
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$19,238
+5,144 vol
$3.74 each
69,713
Filed 2020-06-10 18:57
Tx date 2020-06-09
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-19,238.56
-5,144 vol
$3.74 each
99,288
Filed 2020-06-02 20:38
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,630 vol
16,796
Filed 2020-06-02 20:37
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$30,780
+8,230 vol
$3.74 each
18,426
Filed 2020-06-02 20:35
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-30,780.20
-8,230 vol
$3.74 each
332,754
Filed 2020-06-02 20:28
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
114,281
Filed 2020-06-02 20:24
Tx date 2020-05-29
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$11,541
+3,086 vol
$3.74 each
122,041
Filed 2020-06-02 20:23
Tx date 2020-05-29
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-11,541.64
-3,086 vol
$3.74 each
104,281
Filed 2020-06-02 20:07
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
104,432
Filed 2020-06-02 20:05
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
48,644
Filed 2020-06-02 20:03
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
70,659
Filed 2020-06-02 19:59
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
64,488
Filed 2020-06-02 19:51
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
35,000
Filed 2020-06-02 19:48
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
52,144
Filed 2020-06-02 19:41
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
68,808
Filed 2020-06-02 19:26
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-43,290
-3,000 vol
$14.43 each
255,186
Filed 2020-06-02 19:24
Tx date 2020-05-29
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-69,950
-5,000 vol
$13.99 each
258,186
Filed 2020-05-28 20:30
Tx date 2020-05-26
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,108 vol
263,186
Filed 2020-05-28 20:28
Tx date 2020-05-26
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$23,083
+6,172 vol
$3.74 each
264,294
Filed 2020-05-28 20:26
Tx date 2020-05-26
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-23,083.28
-6,172 vol
$3.74 each
1,191,348
Filed 2020-03-16 16:49
Tx date 2020-03-12
$XENE
Xenon Pharmaceuticals Inc.
Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+65,000 vol
180,000
Filed 2020-03-16 16:43
Tx date 2020-03-12
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+65,000 vol
237,500
Filed 2020-03-16 16:37
Tx date 2020-03-12
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+280,000 vol
1,197,520
Filed 2020-03-16 16:33
Tx date 2020-03-12
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+145,000 vol
674,340
Filed 2020-03-16 16:26
Tx date 2020-03-12
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+65,000 vol
340,984
Filed 2020-01-14 15:11
Tx date 2020-01-13
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
25,000
Filed 2020-01-14 15:07
Tx date 2020-01-13
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-17 17:22
Tx date 2019-12-16
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-11,541.64
-3,086 vol
$3.74 each
58,808
Filed 2019-12-17 17:19
Tx date 2019-12-16
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$11,541
+3,086 vol
$3.74 each
60,647
Filed 2019-12-06 17:25
Tx date 2019-12-04
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-7,693.18
-2,057 vol
$3.74 each
60,659
Filed 2019-12-06 17:23
Tx date 2019-12-04
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,693
+2,057 vol
$3.74 each
21,516
Filed 2019-11-22 16:20
Tx date 2019-11-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-7,693.18
-2,057 vol
$3.74 each
94,432
Filed 2019-11-22 16:17
Tx date 2019-11-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
$-7,693.18
-2,057 vol
$3.74 each
64,569
Filed 2019-11-22 16:16
Tx date 2019-11-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,693
+2,057 vol
$3.74 each
66,626
Filed 2019-11-22 16:12
Tx date 2019-11-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-19,238.56
-5,144 vol
$3.74 each
96,489
Filed 2019-11-22 16:10
Tx date 2019-11-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
$-19,238.56
-5,144 vol
$3.74 each
64,569
Filed 2019-11-22 16:08
Tx date 2019-11-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$19,238
+5,144 vol
$3.74 each
69,713
Filed 2019-09-24 18:26
Tx date 2019-09-20
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-98,856.45
-10,395 vol
$9.51 each
258,122
Filed 2019-09-20 16:24
Tx date 2019-09-20
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-48,884.34
-5,206 vol
$9.39 each
118,955
Filed 2019-09-20 16:23
Tx date 2019-09-19
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-70,452
-7,600 vol
$9.27 each
124,161
Filed 2019-09-20 13:02
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$424,800
+45,000 vol
$9.44 each
275,984
Filed 2019-09-19 20:21
Tx date 2019-09-18
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,535.04
-4,368 vol
$9.28 each
131,761
Filed 2019-09-19 20:20
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-47,243.08
-5,069 vol
$9.32 each
136,129
Filed 2019-09-19 20:18
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$141,600
+15,000 vol
$9.44 each
107,367
Filed 2019-09-19 19:38
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$2,643,200
+280,000 vol
$9.44 each
975,132
Filed 2019-09-19 19:35
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$32,362
+8,653 vol
$3.74 each
268,517
Filed 2019-09-19 19:34
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-3,692 vol
917,520
Filed 2019-09-19 19:33
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-32,362.22
-8,653 vol
$3.74 each
921,212
Filed 2019-09-19 19:32
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$24,272
+6,490 vol
$3.74 each
259,864
Filed 2019-09-19 19:31
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-2,769 vol
929,865
Filed 2019-09-19 19:30
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-24,272.60
-6,490 vol
$3.74 each
932,634
Filed 2019-09-19 19:29
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$94,393
+25,239 vol
$3.74 each
253,374
Filed 2019-09-19 19:27
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-10,769 vol
939,124
Filed 2019-09-19 19:26
Tx date 2019-09-17
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-94,393.86
-25,239 vol
$3.74 each
949,893
Filed 2019-09-19 17:24
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$67,091
+17,939 vol
$3.74 each
141,198
Filed 2019-09-19 17:23
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-7,781 vol
92,367
Filed 2019-09-19 17:22
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-67,091.86
-17,939 vol
$3.74 each
100,148
Filed 2019-09-19 17:21
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,048
+2,152 vol
$3.74 each
123,259
Filed 2019-09-19 17:19
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-934 vol
118,087
Filed 2019-09-19 17:18
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,048.48
-2,152 vol
$3.74 each
119,021
Filed 2019-09-19 17:16
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,048
+2,152 vol
$3.74 each
121,107
Filed 2019-09-19 17:15
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-934 vol
121,173
Filed 2019-09-19 17:13
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,048.48
-2,152 vol
$3.74 each
122,107
Filed 2019-09-19 15:56
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$141,600
+15,000 vol
$9.44 each
42,144
Filed 2019-09-19 15:22
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$613,600
+65,000 vol
$9.44 each
115,000
Filed 2019-09-19 15:17
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$377,600
+40,000 vol
$9.44 each
172,500
Filed 2019-09-19 15:13
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,274,400
+135,000 vol
$9.44 each
529,340
Filed 2019-09-19 15:07
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$141,600
+15,000 vol
$9.44 each
54,488
Filed 2019-09-19 14:50
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$141,600
+15,000 vol
$9.44 each
62,716
Filed 2019-09-19 14:34
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$141,600
+15,000 vol
$9.44 each
45,230
Filed 2019-09-19 14:17
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$141,600
+15,000 vol
$9.44 each
38,644
Filed 2019-09-19 14:05
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$141,600
+15,000 vol
$9.44 each
101,633
Filed 2019-09-18 21:29
Tx date 2019-09-13
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-214.1806
-23 vol
$9.31 each
57,561
Filed 2019-09-18 21:24
Tx date 2019-09-16
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$141,600
+15,000 vol
$9.44 each
61,894
Filed 2019-09-18 21:07
Tx date 2019-09-13
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-214.1806
-23 vol
$9.31 each
Filed 2019-09-18 20:24
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$16,096
+4,304 vol
$3.74 each
10,196
Filed 2019-09-18 20:17
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-1,868 vol
230,984
Filed 2019-09-18 20:15
Tx date 2019-09-12
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-16,096.96
-4,304 vol
$3.74 each
232,852
Filed 2019-05-22 20:34
Tx date 2019-05-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-7,693.18
-2,057 vol
$3.74 each
86,633
Filed 2019-05-22 20:31
Tx date 2019-05-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,693
+2,057 vol
$3.74 each
64,569
Filed 2019-03-20
Tx date 2019-03-19
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options

-20,576 vol
41,152
Filed 2019-03-20
Tx date 2019-03-19
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options
$76,954
+20,576 vol
$3.74 each
50,924
Filed 2019-03-14
Tx date 2019-03-11
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift

-24,045 vol
Filed 2019-03-14
Tx date 2019-03-11
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift

-24,045 vol
107,562
Filed 2019-03-14
Tx date 2019-03-11
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Sandra Hayden (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift

+17,337 vol
114,403
Filed 2018-12-26
Tx date 2018-12-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift

-5,000 vol
62,512
Filed 2018-12-18
Tx date 2018-12-14
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-7,693.18
-2,057 vol
$3.74 each
47,716
Filed 2018-12-18
Tx date 2018-12-14
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,693
+2,057 vol
$3.74 each
19,459
Filed 2018-12-13
Tx date 2018-12-11
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$15,390
+4,115 vol
$3.74 each
8,194
Filed 2018-12-13
Tx date 2018-12-11
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,644 vol
6,550
Filed 2018-12-13
Tx date 2018-12-11
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-15,390.10
-4,115 vol
$3.74 each
160,915
Filed 2018-12-10
Tx date 2018-12-06
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$11,541
+3,086 vol
$3.74 each
57,584
Filed 2018-12-10
Tx date 2018-12-06
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-11,541.64
-3,086 vol
$3.74 each
46,894
Filed 2018-06-22
Tx date 2018-06-21
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$38,477
+10,288 vol
$3.74 each
54,498
Filed 2018-06-22
Tx date 2018-06-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-5,144 vol
88,690
Filed 2018-06-22
Tx date 2018-06-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-2,057 vol
93,834
Filed 2018-06-22
Tx date 2018-06-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$46,170
+12,345 vol
$3.74 each
67,512
Filed 2018-06-22
Tx date 2018-06-21
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-5,144 vol
95,891
Filed 2018-06-22
Tx date 2018-06-21
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-10,288 vol
49,980
Filed 2018-06-15
Tx date 2018-06-14
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-2,856 vol
49,773
Filed 2018-06-15
Tx date 2018-06-14
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$20,098
+5,374 vol
$3.74 each
17,402
Filed 2018-06-15
Tx date 2018-06-14
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-5,374 vol
52,629
Filed 2018-06-05
Tx date 2018-06-04
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$93,000
+15,000 vol
$6.20 each
60,268
Filed 2018-06-05
Tx date 2018-06-04
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$93,000
+15,000 vol
$6.20 each
101,035
Filed 2018-06-05
Tx date 2018-06-04
$XENE
Xenon Pharmaceuticals Inc.
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$93,000
+15,000 vol
$6.20 each
23,644
Filed 2018-06-05
Tx date 2018-06-04
$XENE
Xenon Pharmaceuticals Inc.
Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$93,000
+15,000 vol
$6.20 each
30,230
Filed 2018-06-05
Tx date 2018-06-04
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$93,000
+15,000 vol
$6.20 each
58,003
Filed 2018-06-05
Tx date 2018-06-04
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$93,000
+15,000 vol
$6.20 each
124,259
Filed 2018-06-05
Tx date 2018-06-04
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$93,000
+15,000 vol
$6.20 each
39,488
Filed 2018-06-05
Tx date 2018-06-04
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$93,000
+15,000 vol
$6.20 each
27,144
Filed 2018-03-20
Tx date 2018-03-19
$XENE
Xenon Pharmaceuticals Inc.
Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20
Tx date 2018-03-19
$XENE
Xenon Pharmaceuticals Inc.
Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
50,000
Filed 2018-03-20
Tx date 2018-03-19
$XENE
Xenon Pharmaceuticals Inc.
Aycardi-Fonseca, Ernesto
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-14
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-11,541.64
-3,086 vol
$3.74 each
109,259
Filed 2018-03-16
Tx date 2018-03-15
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-1,928 vol
237,156
Filed 2018-03-16
Tx date 2018-03-15
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-4,330.92
-1,158 vol
$3.74 each
239,084
Filed 2018-03-16
Tx date 2018-03-15
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$4,330
+1,158 vol
$3.74 each
5,892
Filed 2018-03-16
Tx date 2018-03-14
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$11,541
+3,086 vol
$3.74 each
118,955
Filed 2018-03-14
Tx date 2018-03-12
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-38,477.12
-10,288 vol
$3.74 each
695,132
Filed 2018-03-14
Tx date 2018-03-12
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$38,477
+10,288 vol
$3.74 each
228,135
Filed 2018-03-13
Tx date 2018-03-12
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
165,030
Filed 2018-03-13
Tx date 2018-03-12
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+55,000 vol
240,242
Filed 2018-03-13
Tx date 2018-03-12
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+140,000 vol
705,420
Filed 2018-03-13
Tx date 2018-03-12
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+105,000 vol
394,340
Filed 2018-03-13
Tx date 2018-03-12
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+45,000 vol
132,500
Filed 2018-03-01
Tx date 2018-02-22
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift

-29,580 vol
131,607
Filed 2018-03-01
Tx date 2018-02-22
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Sandra Hayden (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift

+21,180 vol
97,066
Filed 2018-02-14
Tx date 2018-02-12
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-4,079 vol
125,030
Filed 2018-02-14
Tx date 2014-11-05
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-02-14
Tx date 2018-02-12
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$15,255
+4,079 vol
$3.74 each
4,079
Filed 2018-02-14
Tx date 2018-02-12
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-22,669 vol
129,109
Filed 2018-01-26
Tx date 2017-08-14
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-12,345 vol
112,345
Filed 2018-01-04
Tx date 2018-01-01
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-3,497 vol
43,003
Filed 2018-01-04
Tx date 2018-01-01
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-6,583 vol
86,035
Filed 2018-01-04
Tx date 2018-01-01
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-3,497 vol
45,268
Filed 2017-11-16
Tx date 2017-11-15
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$33,280
+15,000 vol
$2.22 each
44,210
Filed 2017-10-24
Tx date 2017-10-23
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+11,000 vol
151,778
Filed 2017-10-24
Tx date 2017-10-23
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+11,000 vol
185,242
Filed 2017-10-24
Tx date 2017-10-23
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+11,000 vol
565,420
Filed 2017-10-24
Tx date 2017-10-23
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
289,340
Filed 2017-10-24
Tx date 2017-10-23
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+11,000 vol
159,585
Filed 2017-10-24
Tx date 2017-10-23
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
87,500
Filed 2017-09-25
Tx date 2017-09-21
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,900
+2,000 vol
$2.95 each
21,210
Filed 2017-09-25
Tx date 2017-09-22
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$23,600
+8,000 vol
$2.95 each
29,210
Filed 2017-08-21
Tx date 2017-08-17
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$60.95
+23 vol
$2.65 each
12,898
Filed 2017-08-21
Tx date 2017-08-18
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,301
+6,312 vol
$2.90 each
19,210
Filed 2017-08-21
Tx date 2016-04-04
$XENE
Xenon Pharmaceuticals Inc.
Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-21
Tx date 2017-08-18
$XENE
Xenon Pharmaceuticals Inc.
Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,995
+1,000 vol
$3.00 each
1,000
Filed 2017-08-17
Tx date 2016-02-08
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-17
Tx date 2017-08-15
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$24,824
+10,000 vol
$2.48 each
10,000
Filed 2017-08-15
Tx date 2017-08-14
$XENE
Xenon Pharmaceuticals Inc.
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$140,770
+50,000 vol
$2.82 each
50,000
Filed 2017-08-15
Tx date 2016-09-27
$XENE
Xenon Pharmaceuticals Inc.
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-14
Tx date 2015-03-16
$XENE
Xenon Pharmaceuticals Inc.
Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-14
Tx date 2017-08-10
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,400
+6,000 vol
$2.90 each
217,847
Filed 2017-08-14
Tx date 2017-08-10
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$20,835
+7,500 vol
$2.78 each
12,500
Filed 2017-08-14
Tx date 2017-08-10
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$29,000
+10,000 vol
$2.90 each
14,300
Filed 2017-08-14
Tx date 2017-08-10
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,225
+5,000 vol
$2.85 each
6,000
Filed 2017-08-14
Tx date 2017-08-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$41,247
+15,000 vol
$2.75 each
161,187
Filed 2017-08-14
Tx date 2017-08-11
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$42,267
+15,000 vol
$2.82 each
15,000
Filed 2017-08-14
Tx date 2015-05-21
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-14
Tx date 2017-08-10
$XENE
Xenon Pharmaceuticals Inc.
Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,950
+7,000 vol
$2.85 each
7,000
Filed 2017-08-10
Tx date 2014-11-05
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-10
Tx date 2017-08-08
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$15,002
+5,000 vol
$3.00 each
5,000
Filed 2017-06-20
Tx date 2017-06-19
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
$-3,844.72
-1,028 vol
$3.74 each
55,167
Filed 2017-06-20
Tx date 2017-06-19
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$3,844
+1,028 vol
$3.74 each
56,195
Filed 2017-06-20
Tx date 2017-06-19
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-3,844.72
-1,028 vol
$3.74 each
92,618
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$4,812
+1,250 vol
$3.85 each
93,646
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,475
+3,500 vol
$3.85 each
48,765
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,475
+3,500 vol
$3.85 each
12,144
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,475
+3,500 vol
$3.85 each
24,488
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,475
+3,500 vol
$3.85 each
124,690
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,475
+3,500 vol
$3.85 each
46,500
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,475
+3,500 vol
$3.85 each
15,230
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,475
+3,500 vol
$3.85 each
8,644
Filed 2017-06-02
Tx date 2017-06-01
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$13,475
+3,500 vol
$3.85 each
92,396
Filed 2017-05-16
Tx date 2017-05-12
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-1,345 vol
174,242
Filed 2017-05-16
Tx date 2017-05-12
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-2,662.88
-712 vol
$3.74 each
175,587
Filed 2017-05-16
Tx date 2017-05-12
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$2,662
+712 vol
$3.74 each
4,734
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options

-4,115 vol
69,443
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options

-4,629 vol
64,814
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options

-3,086 vol
61,728
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options
$11,541
+3,086 vol
$3.74 each
30,348
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-25,720 vol
26,132
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-5,144 vol
20,988
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$67,334
+18,004 vol
$3.74 each
115,323
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$96,192
+25,720 vol
$3.74 each
141,043
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$19,238
+5,144 vol
$3.74 each
146,187
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options
$15,390
+4,115 vol
$3.74 each
22,633
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options
$17,312
+4,629 vol
$3.74 each
27,262
Filed 2017-03-15
Tx date 2017-03-14
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-18,004 vol
51,852
Filed 2017-03-14
Tx date 2017-03-13
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+27,500 vol
176,299
Filed 2017-03-14
Tx date 2017-03-13
$XENE
Xenon Pharmaceuticals Inc.
Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
55,000
Filed 2017-03-14
Tx date 2017-03-13
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+27,500 vol
67,500
Filed 2017-03-14
Tx date 2017-03-13
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
140,778
Filed 2017-03-14
Tx date 2017-03-13
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+27,500 vol
148,585
Filed 2017-03-14
Tx date 2017-03-13
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+75,000 vol
264,340
Filed 2017-03-14
Tx date 2017-03-13
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+140,000 vol
554,420
Filed 2017-01-27
Tx date 2017-01-26
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift

-7,201 vol
55,167
Filed 2016-12-19
Tx date 2016-12-15
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-235,500
-30,000 vol
$7.85 each
115,869
Filed 2016-12-13
Tx date 2016-12-12
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-53,867.22
-14,403 vol
$3.74 each
88,896
Filed 2016-12-13
Tx date 2016-12-12
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$26,935
+7,202 vol
$3.74 each
69,570
Filed 2016-12-13
Tx date 2016-12-12
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$26,931
+7,201 vol
$3.74 each
62,368
Filed 2016-12-13
Tx date 2016-12-12
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
$-26,935.48
-7,202 vol
$3.74 each
62,368
Filed 2016-12-08
Tx date 2016-12-06
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$29,703
+7,942 vol
$3.74 each
12,028
Filed 2016-12-08
Tx date 2016-12-06
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-46,170.30
-12,345 vol
$3.74 each
43,000
Filed 2016-12-02
Tx date 2016-12-01
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$29,684
+7,937 vol
$3.74 each
12,875
Filed 2016-12-02
Tx date 2016-12-01
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-46,170.30
-12,345 vol
$3.74 each
45,265
Filed 2016-09-27
Tx date 2016-09-27
$XENE
Xenon Pharmaceuticals Inc.
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+5,144 vol
5,144
Filed 2016-09-27
Tx date 2016-09-27
$XENE
Xenon Pharmaceuticals Inc.
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-08-23
Tx date 2016-08-19
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-91,337.638
-11,938 vol
$7.65 each
145,869
Filed 2016-08-18
Tx date 2016-08-18
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-73,912.30
-9,599 vol
$7.70 each
157,807
Filed 2016-08-18
Tx date 2016-08-17
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,624
-1,600 vol
$7.89 each
167,406
Filed 2016-08-18
Tx date 2016-08-16
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-56,619.75
-6,863 vol
$8.25 each
169,006
Filed 2016-08-02
Tx date 2016-07-29
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$28,581
+7,642 vol
$3.74 each
211,847
Filed 2016-08-02
Tx date 2016-07-29
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-12,345 vol
414,420
Filed 2016-06-28
Tx date 2016-06-24
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,190
+1,300 vol
$6.30 each
4,300
Filed 2016-06-28
Tx date 2014-11-05
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-28
Tx date 2016-06-24
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,150
+1,000 vol
$6.15 each
1,000
Filed 2016-06-28
Tx date 2014-11-05
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-28
Tx date 2016-06-24
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$12,500
+2,000 vol
$6.25 each
3,000
Filed 2016-06-28
Tx date 2016-06-24
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Holder: Katie Mortimer (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,100
+1,000 vol
$6.10 each
1,000
Filed 2016-06-03
Tx date 2016-06-02
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,830
+3,500 vol
$7.38 each
8,644
Filed 2016-06-03
Tx date 2016-06-02
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,830
+3,500 vol
$7.38 each
57,610
Filed 2016-06-03
Tx date 2016-06-02
$XENE
Xenon Pharmaceuticals Inc.
Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,830
+3,500 vol
$7.38 each
11,730
Filed 2016-06-03
Tx date 2016-06-02
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$9,225
+1,250 vol
$7.38 each
103,299
Filed 2016-06-03
Tx date 2016-06-02
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,830
+3,500 vol
$7.38 each
102,049
Filed 2016-06-03
Tx date 2016-06-02
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,830
+3,500 vol
$7.38 each
55,345
Filed 2016-06-03
Tx date 2016-06-02
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,830
+3,500 vol
$7.38 each
121,190
Filed 2016-06-03
Tx date 2016-06-02
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,830
+3,500 vol
$7.38 each
69,856
Filed 2016-05-27
Tx date 2016-05-25
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
$-30,780.20
-8,230 vol
$3.74 each
73,558
Filed 2016-05-27
Tx date 2016-05-25
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options
$30,780
+8,230 vol
$3.74 each
18,518
Filed 2016-04-29
Tx date 2016-04-28
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
47 - Acquisition or disposition by gift
$-5,770.82
-1,543 vol
$3.74 each
98,549
Filed 2016-04-04
Tx date 2016-04-04
$XENE
Xenon Pharmaceuticals Inc.
Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-04
Tx date 2016-04-04
$XENE
Xenon Pharmaceuticals Inc.
Winquist, Raymond
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+35,000 vol
35,000
Filed 2016-03-11
Tx date 2016-03-11
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
121,085
Filed 2016-03-11
Tx date 2016-03-11
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
120,778
Filed 2016-03-11
Tx date 2016-03-11
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
426,765
Filed 2016-03-11
Tx date 2016-03-11
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
189,340
Filed 2016-03-11
Tx date 2016-03-11
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
148,799
Filed 2016-02-10
Tx date 2016-02-08
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
40,000
Filed 2016-02-10
Tx date 2016-02-08
$XENE
Xenon Pharmaceuticals Inc.
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-21
Tx date 2015-12-18
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
128,799
Filed 2015-12-21
Tx date 2015-12-18
$XENE
Xenon Pharmaceuticals Inc.
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
95,778
Filed 2015-12-21
Tx date 2015-12-18
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
101,085
Filed 2015-12-21
Tx date 2015-12-18
$XENE
Xenon Pharmaceuticals Inc.
Mortimer, Ian Charles
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
149,340
Filed 2015-12-21
Tx date 2015-12-18
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
376,765
Filed 2015-12-18
Tx date 2015-12-16
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$1,104
+182 vol
$6.07 each
4,022
Filed 2015-12-18
Tx date 2015-12-16
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-2,494.77
-411 vol
$6.07 each
113,799
Filed 2015-12-14
Tx date 2015-12-11
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-14,986.83
-2,469 vol
$6.07 each
54,110
Filed 2015-12-14
Tx date 2015-12-11
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$14,986
+2,469 vol
$6.07 each
4,938
Filed 2015-11-25
Tx date 2015-11-24
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$6,446
+1,062 vol
$6.07 each
175,869
Filed 2015-11-25
Tx date 2015-11-24
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-12,485.99
-2,057 vol
$6.07 each
117,690
Filed 2015-11-06
Tx date 2015-11-04
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-21,226.79
-3,497 vol
$6.07 each
51,845
Filed 2015-11-06
Tx date 2015-11-02
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
47 - Acquisition or disposition by gift
$-30,598.87
-5,041 vol
$6.07 each
100,092
Filed 2015-11-06
Tx date 2015-11-04
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$9,359
+1,542 vol
$6.07 each
4,086
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$1,292
+213 vol
$6.07 each
6,316
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-2,057 vol
114,005
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-1,028 vol
112,977
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-5,144 vol
107,833
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-6,172 vol
101,661
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-7,973 vol
86,870
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-785 vol
86,085
Filed 2015-09-26
Tx date 2015-09-24
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-103,200
-12,000 vol
$8.60 each
6,000
Filed 2015-09-26
Tx date 2015-09-23
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-36,080
-4,000 vol
$9.02 each
18,000
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-57,370.17
-6,149 vol
$9.33 each
22,000
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$1,650
+618 vol
$2.67 each
28,149
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$16,783
+6,286 vol
$2.67 each
27,531
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,198
+2,192 vol
$3.74 each
21,245
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$9,742
+2,605 vol
$3.74 each
19,053
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$16,242
+4,343 vol
$3.74 each
16,448
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$13,535
+3,619 vol
$3.74 each
12,105
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$2,704
+723 vol
$3.74 each
8,486
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$5,411
+1,447 vol
$3.74 each
7,763
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-411 vol
116,062
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-3,703 vol
97,958
Filed 2015-09-26
Tx date 2015-09-22
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-3,115 vol
94,843
Filed 2015-08-20
Tx date 2015-08-18
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-2,057 vol
119,747
Filed 2015-08-20
Tx date 2015-08-18
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$10,822
+1,783 vol
$6.07 each
3,840
Filed 2015-08-20
Tx date 2015-08-18
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$72,220
+11,898 vol
$6.07 each
204,205
Filed 2015-08-20
Tx date 2015-08-18
$XENE
Xenon Pharmaceuticals Inc.
Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-3,085 vol
114,210
Filed 2015-08-20
Tx date 2015-08-18
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,217
+1,189 vol
$6.07 each
174,807
Filed 2015-08-20
Tx date 2015-08-18
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-3,085 vol
116,473
Filed 2015-08-20
Tx date 2015-08-18
$XENE
Xenon Pharmaceuticals Inc.
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$10,822
+1,783 vol
$6.07 each
6,103
Filed 2015-08-20
Tx date 2015-08-18
$XENE
Xenon Pharmaceuticals Inc.
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-20,576 vol
336,765
Filed 2015-06-19
Tx date 2015-06-17
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-9,366.01
-1,543 vol
$6.07 each
105,133
Filed 2015-06-19
Tx date 2015-06-17
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$9,366
+1,543 vol
$6.07 each
55,167
Filed 2015-05-25
Tx date 2015-05-21
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+5,144 vol
5,144
Filed 2015-05-25
Tx date 2015-05-21
$XENE
Xenon Pharmaceuticals Inc.
Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-05-08
Tx date 2015-01-07
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$21,226
+3,497 vol
$6.07 each
Filed 2015-05-08
Tx date 2014-11-05
$XENE
Xenon Pharmaceuticals Inc.
Evans, Johnston Livingston
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
5,144
Filed 2015-05-08
Tx date 2015-01-07
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$15,442
+2,544 vol
$6.07 each
2,544
Filed 2015-05-08
Tx date 2015-05-04
$XENE
Xenon Pharmaceuticals Inc.
Evans, Johnston Livingston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+3,086 vol
8,230
Filed 2015-05-07
Tx date 2015-05-04
$XENE
Xenon Pharmaceuticals Inc.
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+3,086 vol
56,579
Filed 2015-05-07
Tx date 2015-05-04
$XENE
Xenon Pharmaceuticals Inc.
Scheller, Richard Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+3,086 vol
8,230
Filed 2015-05-07
Tx date 2015-05-04
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+1,028 vol
106,676
Filed 2015-05-07
Tx date 2015-05-04
$XENE
Xenon Pharmaceuticals Inc.
Patou, Gary
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+3,086 vol
55,342
Filed 2015-05-07
Tx date 2015-05-04
$XENE
Xenon Pharmaceuticals Inc.
Holler, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+3,086 vol
121,804
Filed 2015-05-07
Tx date 2015-05-04
$XENE
Xenon Pharmaceuticals Inc.
Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+3,086 vol
66,356
Filed 2015-05-07
Tx date 2015-05-04
$XENE
Xenon Pharmaceuticals Inc.
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+3,086 vol
105,648
Filed 2015-05-05
Tx date 2015-04-30
$XENE
Xenon Pharmaceuticals Inc.
Stein, Evan Albert
4 - Director of Issuer
Holder: Lipoterx Ltd. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

-1,038,964 vol
0
Filed 2015-05-05
Tx date 2015-04-30
$XENE
Xenon Pharmaceuticals Inc.
Stein, Evan Albert
4 - Director of Issuer
Holder: Lipoterx Holdings, LLC (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

+4,172 vol
4,172
Filed 2015-05-05
Tx date 2014-11-05
$XENE
Xenon Pharmaceuticals Inc.
Stein, Evan Albert
4 - Director of Issuer
Holder: Lipoterx Holdings, LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-05-05
Tx date 2015-04-30
$XENE
Xenon Pharmaceuticals Inc.
Stein, Evan Albert
4 - Director of Issuer
Holder: Stein Family, LLC (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

+909,619 vol
910,586